Jointly Owned Technology. All Joint Program Technology and Joint Improvements shall be jointly owned by ImmunoGen and Lilly. The Parties shall also jointly own any Patent Rights claiming such Joint Program Technology and Joint Improvements. Portions of this Exhibit, indicated by the xxxx “[***],” were omitted and have been filed separately with the Securities and Exchange Commission pursuant to the Registrant’s application requesting confidential treatment pursuant to Rule 24b-2 of the Securities Exchange Act of 1934, as amended.
Appears in 3 contracts
Samples: Confidential Treatment Requested (Immunogen Inc), Confidential Treatment Requested (Immunogen Inc), License Agreement (Immunogen Inc)
Jointly Owned Technology. All Joint Program Technology and Joint Improvements shall be jointly owned by ImmunoGen and LillyNovartis. The Parties shall also jointly own any Patent Rights claiming such Joint Program Technology and Joint Improvements. Portions of this Exhibit, indicated by the xxxx “[***],” were omitted and have been filed separately with the Securities and Exchange Commission pursuant to the Registrant’s application requesting confidential treatment pursuant to Rule 24b-2 of the Securities Exchange Act of 1934, as amended.
Appears in 2 contracts
Samples: Confidential Treatment Requested (Immunogen Inc), Multi Target Agreement (Immunogen Inc)
